
About Little Green Pharma
Little Green Pharma is a publicly listed company based in Perth (Australia) founded in 2016 by Fleta Solomon. Little Green Pharma has raised $1.91 million across 3 funding rounds from investors including Fastforward Innovations. Little Green Pharma has completed 1 acquisition, including Fastforward Innovations. Its chief executive, as recorded, is Paul Long. Little Green Pharma offers products and services including THC:CBD Cannabis Oil and Medical Cannabis Medicines. Its focus areas include HealthTech, Cannabis HealthTech, Cannabinoid Therapeutics and Diversified.
Company details
Manufacturer of medicinal cannabis for therapeutic use. The company produces cannabis oils by extracting them from the whole plant along with medium-chain triglyceride (MCT) oil. The companys small particle formulations include Plus and Natural which are made using different ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD). The company has also developed anti-solvent extraction technology ARISE that is used to increase the surface area of active pharmaceuticals to improve the drug absorption potential.
- Annual Revenue$29.22 M (USD)15.21as on Mar 31, 2026
- Net Profit-$971.2 K (USD)-142.36as on Mar 31, 2026
- EBITDA$1.27 M (USD)as on Mar 31, 2026
- Total Equity Funding$1.91M (USD)
in 3 rounds
- Latest Funding Round$5M (USD), Post-IPO
Mar 2023
- Investors
- Investments & Acquisitions
Products & Services of Little Green Pharma
Little Green Pharma offers a comprehensive portfolio of products and services, including THC:CBD Cannabis Oil and Medical Cannabis Medicines.
Balanced oil for relieving refractory pain in patients.
High-quality products for managing chronic health conditions.
Apps and channels of Little Green Pharma
its YouTube channel Little Green Pharma has 490 subscribers.
Funding Insights of Little Green Pharma
Little Green Pharma has successfully raised a total of $1.91M across 3 strategic funding rounds. The most recent funding activity was a Post-IPO round of $5 million completed in March 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $1.91M
- Total Rounds 3
- Last Round Post-IPO β $5M
- First Round $1.91M
(Oct 2017)
- Investors Count 1
All 3 funding rounds of Little Green Pharma with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Mar 2023 | $5M | Post-IPO | β | β | β |
| Feb 2021 | Post-IPO | β | β | ||
| Oct 2017 | $1.91M | Seed | β | β | β |
1 investors in total: 1 institutional.
Investors in Little Green Pharma
Little Green Pharma has secured backing from 1 investor, including venture fund investors. Prominent investors backing the company include Fastforward Innovations.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Tech & life Science focused early stage VC firm investing in North America & Europe | 2006 | fstfwd.co | Saint Peter Port, Guernsey |
Investor details for Little Green Pharma
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Little Green Pharma
2 people are tracked at Little Green Pharma (2 in leadership).
| Name | Role | Group |
|---|---|---|
Fleta Solomon | Founder | Leadership |
Paul Long | CEO | Leadership |
Complete people profiles for Little Green Pharma
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
IPO & Listings of Little Green Pharma
Little Green Pharma is a publicly listed company on the ASX with ticker symbol LGP in Australia, operating in the Process industries sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
- IPO date20 Feb 2020
- Listed onASX: LGP
- Listed entityLITTLE GREEN PHARMA LTD
- Exchange sectorProcess industries
- ISINAU0000074924
- Share price0.06 AUD (-5.97% on the day) · 2026-10-14
- Market capitalisation55,474,574.00 AUD
- Price to earnings6.4
- EPS (diluted, trailing year)-0.00 AUD
- Volume (last session)17,221
Financials of Little Green Pharma
| Year | Revenue | Net income | EBITDA |
|---|---|---|---|
| 2025 | 42.4M AUD | -1.4M AUD | 1.9M AUD |
| 2024 | 36.8M AUD | 3.3M AUD | -325,000 AUD |
| 2023 | 25.6M AUD | -8.2M AUD | -5.5M AUD |
| 2022 | 19.9M AUD | -8.6M AUD | -11.5M AUD |
| 2021 | 14.0M AUD | -24.1M AUD | -27.0M AUD |
Detailed financial statements for Little Green Pharma
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Little Green Pharma
Little Green Pharma has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include Fastforward Innovations.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Tech & life Science focused early stage VC firm investing in North America & Europe | fstfwd.co | Saint Peter Port, Guernsey | 2006 | Jun 2021 | β’β’β’β’ |
Complete acquisition details for Little Green Pharma
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Little Green Pharma
5 dated milestones of Little Green Pharma across 7 years, from founding to its latest funding, stage changes and deals.
- Founded Little Green Pharma is founded.
- Funding First funding round of $1.9M.
- IPO Lists on the stock exchange (IPO).
- Acquisition Acquires Fastforward Innovations.
- Funding Latest funding round, Post-IPO, of $5.0M.
Web traffic of Little Green Pharma
The website of Little Green Pharma (littlegreenpharma.com) receives about 8.7K visits a month.
- Monthly visits8.7K
▲ 13.2% vs previous month
Websites whose visitors overlap most with Little Green Pharma. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
listcorp.com | listcorp.com | 100% | #193,319 | β | |
naturecan.com.au | naturecan.com.au | 36% | #508,154 | β | |
| hellomello.com.au | 34% | 19.7K | #904,178 | View details | |
| kind.com.au | 34% | 14.4K | #1,500,585 | View details | |
| cannafind.com.au | 32% | 5.4K | #4,170,062 | View details | |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
| β’β’β’β’β’β’β’β’β’β’ | β’β’β’β’β’β’.com | β’β’% | β’.β’M | #β’β’β’β’β’ | β |
All 9 similar websites and full traffic analytics for Little Green Pharma
The complete similar-websites list, audience overlap and engagement analytics require an active premium plan.
- 9 similar websites
- Audience overlap
- Engagement analytics
- Traffic by brand
Verified entity values are shown only after access is granted.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Little Green Pharma
Complete news archive for Little Green Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Little Green Pharma
Little Green Pharma was founded in 2016 and raised its 1st funding round 1 year after it was founded.
Little Green Pharma is headquartered in Perth, Australia. It is registered at Perth, Western Australia, Australia.
Paul Long is the CEO of Little Green Pharma, as recorded in our data.
Little Green Pharma is a funded company, having raised a total of $1.91M across 3 funding rounds to date. The company's 1st funding round was a Seed of $1.91M, raised on Oct 2017.
Annual revenue of Little Green Pharma is $29.22M as on Mar 31, 2026.
Manufacturer of medicinal cannabis for therapeutic use. The company produces cannabis oils by extracting them from the whole plant along with medium-chain triglyceride (MCT) oil. The companys small particle formulations include Plus and Natural which are made using different ratios of tetrahydrocannabinol (THC) and cannabidiol (CBD). The company has also developed anti-solvent extraction technology ARISE that is used to increase the surface area of active pharmaceuticals to improve the drug absorption potential.
Little Green Pharma offers THC:CBD Cannabis Oil and Medical Cannabis Medicines.
Yes, Little Green Pharma is publicly traded on ASX under the ticker symbol LGP.
Little Green Pharma has made 1 acquisition, including Fastforward Innovations.
Little Green Pharma has 1 investor. Key investors include Fastforward Innovations.
